AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Erythromycin in South Africa
7 products registered with SAHPRA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| RUBIMYCIN EYE OINTMENT | W/15.1/447 | Pharmacare Limited û Woodmead | suspended | 30 Nov 2022 |
| ERYMAX PAEDIATRIC SPRINKLE 125 mg* | V/20.1.1/0005 | WARNER-LAMBERT SA (PTY) LTD | suspended | 30 Jun 2022 |
| ERYDERM | Q/20.1.1/248 | Pharmaco Distribution (Pty) Ltd | suspended | 1 Jun 2022 |
| ERYTHROMID | C/20.1.1/97 | Pharmaco Distribution (Pty) Ltd | suspended | 1 Jun 2022 |
| ERYMAX* | R/20.1.1/78 | WARNER-LAMBERT SA (PTY) LTD | active | 25 Aug 1991 |
| ERYTHROCIN* SUPPOSITORY | C/20.1.1/98 | Abbott Laboratories S.A. (Pty) Ltd | active | 1 Jan 1900 |
| ILOTYCIN T.S. | M/20.1.6/80 | Pharmacare Limited û Woodmead | active | 1 Jan 1900 |
Erythromycin — SAHPRA Registration Details
SAHPRA (South Africa) has 7 registered products containing Erythromycin, of which 3 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Erythromycin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.